Key Details
Price
$10.25Annual ROE
-54.00%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Feb 27, 2025Recent annual earnings:
Feb 27, 2025Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Mar 5, 25 HC Wainwright & Co.
BuyMar 4, 25 Truist Securities
BuyFeb 28, 25 Wells Fargo
OverweightFeb 28, 25 JP Morgan
NeutralFeb 28, 25 Citigroup
NeutralFeb 28, 25 Chardan Capital
BuyFeb 28, 25 Barclays
OverweightJan 27, 25 Morgan Stanley
Equal-WeightJan 14, 25 Goldman Sachs
NeutralJan 13, 25 Oppenheimer
OutperformMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Intellia Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Intellia Therapeutics?
- Does Intellia Therapeutics pay dividends?
- What sector is Intellia Therapeutics in?
- What industry is Intellia Therapeutics in?
- What country is Intellia Therapeutics based in?
- When did Intellia Therapeutics go public?
- Is Intellia Therapeutics in the S&P 500?
- Is Intellia Therapeutics in the NASDAQ 100?
- Is Intellia Therapeutics in the Dow Jones?
- When was Intellia Therapeutics's last earnings report?
- When does Intellia Therapeutics report earnings?
- Should I buy Intellia Therapeutics stock now?
What is the ticker symbol for Intellia Therapeutics?
The ticker symbol for Intellia Therapeutics is NASDAQ:NTLA
Does Intellia Therapeutics pay dividends?
No, Intellia Therapeutics does not pay dividends
What sector is Intellia Therapeutics in?
Intellia Therapeutics is in the Healthcare sector
What industry is Intellia Therapeutics in?
Intellia Therapeutics is in the Biotechnology industry
What country is Intellia Therapeutics based in?
Intellia Therapeutics is headquartered in United States
When did Intellia Therapeutics go public?
Intellia Therapeutics's initial public offering (IPO) was on May 6, 2016
Is Intellia Therapeutics in the S&P 500?
No, Intellia Therapeutics is not included in the S&P 500 index
Is Intellia Therapeutics in the NASDAQ 100?
No, Intellia Therapeutics is not included in the NASDAQ 100 index
Is Intellia Therapeutics in the Dow Jones?
No, Intellia Therapeutics is not included in the Dow Jones index
When was Intellia Therapeutics's last earnings report?
Intellia Therapeutics's most recent earnings report was on Feb 27, 2025
When does Intellia Therapeutics report earnings?
The date for Intellia Therapeutics's next earnings report has not been announced yet
Should I buy Intellia Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions